Learn what Casgevy (exagamglogene autotemcel) is, how this CRISPR/Cas9-based gene therapy edits hematopoietic stem cells, reactivates fetal hemoglobin (HbF), and offers long-term relief for sickle cell disease and transfusion-dependent β-thalassemia.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs